Kanda N - Search Results

1

Role of triglyceride levels in identifying insulin resistance in nonobese type 2 diabetic Japanese patients with hypertension.

Taniguchi A, Fukushima M, Sakai M, Nagata I, Nagasaka S, Doi K, Kinoshita H, Kanda N, Tokuyama K, Nakai Y. Taniguchi A, et al. Among authors: kanda n. Diabetes Care. 2000 Jun;23(6):856-7. doi: 10.2337/diacare.23.6.856. Diabetes Care. 2000. PMID: 10841009 No abstract available.

2

Preferred practice pattern of physicians regarding diabetic retinopathy in diabetes mellitus patients.

Moudgil T, Bains BK, Bandhu S, Kanda N. Moudgil T, et al. Among authors: kanda n. Indian J Ophthalmol. 2021 Nov;69(11):3139-3143. doi: 10.4103/ijo.IJO_1339_21. Indian J Ophthalmol. 2021. PMID: 34708757 Free PMC article.

3

Effectiveness and safety of tralokinumab treatment for moderate-to-severe atopic dermatitis in real-world clinical practice in Japan.

Hagino T, Onda M, Saeki H, Fujimoto E, Kanda N. Hagino T, et al. Among authors: kanda n. Eur J Dermatol. 2024 Oct 1;34(5):525-532. doi: 10.1684/ejd.2024.4750. Eur J Dermatol. 2024. PMID: 39589036

4

Effectiveness of long-term bimekizumab treatment and predictive factors for responders in moderate-to-severe psoriasis: A 52-week real-world study.

Hagino T, Saeki H, Fujimoto E, Kanda N. Hagino T, et al. Among authors: kanda n. J Dermatol. 2024 Nov 5. doi: 10.1111/1346-8138.17532. Online ahead of print. J Dermatol. 2024. PMID: 39498997

5

Effect of calcium channel blockers on influenza incidence: a population-based retrospective cohort study using administrative claims data in Japan.

Imai T, Hashimoto H, Kanda N, Sasabuchi Y, Matsui H, Yasunaga H, Hatakeyama S. Imai T, et al. Among authors: kanda n. BMJ Open. 2024 Oct 15;14(10):e084092. doi: 10.1136/bmjopen-2024-084092. BMJ Open. 2024. PMID: 39414280 Free PMC article.

6

Treatment of chronic hand eczema with topical anti-inflammatory drugs other than topical corticosteroids.

Saeki H, Kanda N. Saeki H, et al. Among authors: kanda n. Med. 2024 Oct 11;5(10):1203-1205. doi: 10.1016/j.medj.2024.08.009. Med. 2024. PMID: 39395404

7

Letter to the Editor-"Effects of early enteral nutrition on persistent inflammation, immunosuppression, and catabolism syndrome in critically ill patients".

Kashiwagi S, Kanda N, Nakamura K. Kashiwagi S, et al. Among authors: kanda n. Clin Nutr. 2024 Nov;43(11):135-136. doi: 10.1016/j.clnu.2024.09.046. Epub 2024 Sep 30. Clin Nutr. 2024. PMID: 39378562 No abstract available.

8

Effectiveness and safety of upadacitinib retreatment after withdrawal in moderate-to-severe atopic dermatitis: a retrospective study.

Hagino T, Saeki H, Fujimoto E, Kanda N. Hagino T, et al. Among authors: kanda n. Clin Exp Dermatol. 2024 Oct 8:llae410. doi: 10.1093/ced/llae410. Online ahead of print. Clin Exp Dermatol. 2024. PMID: 39378322

9

Effects of Tralokinumab on Clinical and Laboratory Indexes in Atopic Dermatitis: A 24-Week Real-World Study.

Hagino T, Onda M, Saeki H, Fujimoto E, Kanda N. Hagino T, et al. Among authors: kanda n. Dermatitis. 2024 Oct 3. doi: 10.1089/derm.2024.0323. Online ahead of print. Dermatitis. 2024. PMID: 39361494

10

Predictive Factors for Long-Term High Responders to Upadacitinib Treatment in Patients with Atopic Dermatitis.

Hagino T, Saeki H, Fujimoto E, Kanda N. Hagino T, et al. Among authors: kanda n. Dermatitis. 2024 Sep 23. doi: 10.1089/derm.2024.0230. Online ahead of print. Dermatitis. 2024. PMID: 39311694

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

446 results

Search Page

Filters